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Abstract
Neurorehabilitation is a rapidly developing subspecialty of neurology due to medical advances and growing knowledge on
functional recovery from brain injury such as plasticity and regeneration in the nervous system. Furthermore, progress in
modern technologies facilitate new therapeutic concepts. Patient-tailored, flexible multimodal neurorehabilitation is
essential in neurological diseases due to the diversity of symptoms. In addition, rehabilitative treatment should be realized
from disease onset. To fulfill these goals, the neurocenter of the Cantonal Hospital Lucerne established an uninterrupted
treatment chain from the emergency stage to the social and occupational reintegration, which is described in this article
with a focus on stroke, Parkinson’s disease, and multiple sclerosis patients.
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Introduction
Neurorehabilitation is a subspecialty of neurology that is
rapidly growing in the last few years because medical
advances have improved survival and extended life expec-
tancy. Furthermore, the science of functional recovery from
brain injury such as plasticity and regeneration in the ner-
vous system has made significant progress.
Patient-tailored neurorehabilitation is essential in
numerous neurological diseases. This implies rehabilitative
treatment from disease onset (stroke or traumatic brain
injury), as well as flexible multimodal rehabilitation in
chronic diseases such as Parkinson’s disease (PD) or mul-
tiple sclerosis (MS).
To fulfill these goals, the neurorehabilitation unit of the
cantonal hospital Lucerne is intimately interconnected to
the neurology, neuroradiology, and neurosurgery services.
The close collaboration of the neurodiscipline within the
neurocenter ensures an uninterrupted patient care from the
emergency stage to the social and occupational reintegra-
tion (https://www.luks.ch/standorte/standort-luzern/neuro
zentrum). The continuous treatment chain of neurorehabil-
itation encompasses several levels: (1) neuropath, (2) inpa-
tient neurorehabilitation, (3) neurorehabilitation day clinic,
(4) outpatient neurorehabilitation, and (5) center for
professional reintegration for patients with brain damages
(ZBA, Zentrum fu¨r berufliche Reintegration; Figure 1).
This article aims to describe the neurorehabilitatory care
of patients in the neurocenter of the Luzerner Kantonsspital
including the main research projects, with emphasis on
stroke, PD, and MS patients.
Neuropath
For patients with acute neurological disease, most com-
monly stroke and traumatic brain injury, a “Neuropath”
(“Neuropfad”) was implemented. A mobile team of neuror-
ehabilitation specialists (physical therapists, occupational
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therapists, language therapists, and neuropsychologists)
assesses patients with regard to the need for neurorehabil-
itation at day 1 of the hospital stay. The team triages and
organizes further steps to avoid delay and starts neuroreh-
abilitative measures. Patients that are initially hospitalized
in acute units of the neurocenter (neurological wards, neu-
rosurgical wards, and stroke unit) are directly transferred to
inpatient neurorehabilitation as early as possible. Patients
initially hospitalized in another department including the
intensive care unit enter the neurorehabilitation directly or
via the neurological entities mentioned above. Importantly,
patients going through the neuropath constantly get neuror-
ehabilitative therapy by the mobile team.
Inpatient neurorehabilitation
The inpatient neurorehabilitation is located in the main
building of the Cantonal Hospital Lucerne, one floor above
the acute neurological ward. Besides specialized neurolo-
gists and nurses, physical therapists, occupational thera-
pists, language therapists, neuropsychologists, and social
workers take care of patients. Patients are screened at entry
as to which therapies are necessary and outcome measure-
ments are evaluated depending on the disease. All patients
are rated by the Lucerne International Classification of
Functioning (ICF)-based multidisciplinary observation
scale (LIMOS) described below at admission and weekly
until discharge. In addition, a core set of standardized out-
come measurements is performed at admission and dis-
charge.1 On average, patients stay for 32 days +19
standard deviation (SD), before many of them enter further
rehabilitation settings described below. From 2015 to 2018,
1342 patients with a mean age of 61.92 years (+37.11 SD,
range: 18–96), 45.67% of them being female, were treated
in the inpatient neurorehabilitation: 65% were stroke
patients, 9% had PD, 9% traumatic brain injury, 3% brain
tumors, 2% MS, and 12% other diseases.
Neurorehabilitation day clinic
The neurorehabilitation day clinic was developed to offer
patients high-frequency therapy in an outpatient setting
after or as an alternative to an inpatient neurorehabilitation.
Based on its intensity, it may also allow earlier discharge
from the inpatient stay. Patients come to the day clinic 4–12
weeks depending on the disease and disease course. Ther-
apy is performed 2–5 days a week. Patients stay a minimum
of 5 h with at least two therapeutic sessions each day. The
day clinic offers a room for relaxation and the possibility to
sleep at noon. Qualified nurses take care of patients.
Furthermore, besides rehabilitation, nursing, and medical
services, social counseling is offered. In 2018, 107 patients
with a mean age of 52.96 years (+15.87 SD, range:
18–80), 35.51% of them being female, were treated in the
neurorehabilitation day clinic with a mean duration of
55 days+31 SD: 70% were stroke patients, 14% traumatic
brain injury, 7% brain tumors, 5% MS, and 4% PD.
Outpatient neurorehabilitation
In addition, we offer an outpatient neurorehabilitation from
one to four times a week (for example, Lee Silverman
Voice Treatment). Physical therapy, occupational therapy,
language therapy, and neuropsychological therapy can be
offered to patients solely or combined, depending on the
needs of the patient.
Home-based rehabilitation
To further improve patient-tailored rehabilitation, several
home-based rehabilitation programs, currently mostly per-
formed within studies, are offered to patients in different
diseases and described in detail below. In general, these
programs are supervised by the outpatient neurorehabilita-
tion team. Home-based rehabilitation is a highly promising
research field that gets facilitated by tablet- and app-based
technologies. It allows frequent training in patients who are
Figure 1. Continuous neurorehabilitatory treatment chain. Neurorehabilitation is offered to patients from day 1 of the hospitalization
in different treatment entities by the same team. All shown person are employees of the Luzerner Kantonsspital and gave consent.
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not able to attend outpatient programs regularly, due to lack
of transportation or work and family duties. Alternatively,
it can be implemented in other therapy programs to
enhance training frequency and broaden the therapeutic
measures. The future goal is to implement home-based
training programs in routine care, reimbursed by the insur-
ance companies.
Center for professional reintegration for
patients with brain damages (ZBA,
Zentrum fu¨r berufliche Reintegration fu¨r
Menschen mit einer Hirnverletzung)
(https://www.zba.ch/)
Health-care professionals of the neurocenter also work in
the center for professional reintegration for patients with
brain damages (ZBA). The ZBA is an independent organi-
zation for the reintegration of brain-damaged patients into
the professional life. This includes the evaluation of
patients with regard to vocational capacities and the super-
vision of the integration of patients into previous or adapted
working environments.
Lucerne ICF-based multidisciplinary
observation scale
A valid detection of a patient’s ability to perform activities
of daily living (ADL) is crucial in rehabilitation procedures
to set measurable treatment goals, to make appropriate dis-
charge arrangements, and to anticipate the need for com-
munity support.2,3 To measure disability in stroke, the
Barthel index (BI), the extended BI, and the modified rank-
ing scale or the functional independent measurement (FIM)
is often used. These measurements however have drawbacks
such as ceiling and floor effects, focus on physical domains,
and were not conceptualized to be comprehensive.4,5
The ICF framework set by the World Health Organiza-
tion (WHO) was developed to optimize measuring health
and disability and has become a standard in neurorehabil-
itation (WHO, World Health Organization. International
Classification of Functioning, Disability and Health: ICF,
Geneva, 2001).6 ICF core-sets were established for stroke,
linking ICF domains with existing standardized measure-
ments.7,8 In addition, self-reported questionnaires and
monodisciplinary observation tools incorporating ICF
domains were developed.9–12 However, self-reported ques-
tionnaires strongly depend on preserved cognitive abilities
(i.e. insight) of patients and monodisciplinary observation
tools do not reflect the whole condition of a stroke patient
within a multidisciplinary rehabilitation setting.
Therefore, we developed the LIMOS which is a multi-
disciplinary observation scale based on the ICF. It includes
seven chapters, overall incorporating 45 items, each item is
rated on a 5-point scale (1–5) (for more details, see Ottiger
et al.1 and Vanbellingen et al.13) (Figure 2).
LIMOS is feasible and showed good reliability and
validity in stroke patients.1 In addition, it showed to be
more responsive than the FIM and the BI to measure
improvements in ADL over time.13 It covers more cogni-
tive functions and shows neither floor nor ceiling effects
and offers the possibility to measure subscales, for instance
the functional role of the upper limb in the ADLs.14
The LIMOS has successfully been used to evaluate the
effects of noninvasive brain stimulation on the ADL in
stroke patients with neglect. In a randomized controlled
trial, continuous theta burst stimulation was shown to sig-
nificantly improve functional outcome as measured by
LIMOS during inpatient neurorehabilitation compared to
sham stimulation.15
Just recently the LIMOS underwent a thorough Rasch-
based analysis, which is a more modern psychometric
evaluation to standardize scales.16 The advantage of
Rasch-based LIMOS is that items can be ordered on a
hierarchical level of difficulty. Besides stroke, the LIMOS
can also be performed in all patients treated in inpatient and
ambulatory settings and further validations in other dis-
eases are warranted.
As mentioned above, the LIMOS is performed regularly
in the inpatient neurorehabilitation and neurorehabilitation
day clinic. As shown in Figure 3, the LIMOS improved
significantly in both treatment entities if all treated patients
are analyzed, indicating that patients did benefit from
neurorehabilitation.
Cognitive neurorehabilitation in stroke
patients
When humans acquire knowledge and understanding
through sensation, experience, or thought, they do so by
performing mental actions or processes denoted by the term
“cognition.” Several cognitive domains can be differen-
tiated, for example, attention, memory, language, or exec-
utive functions. Patients with stroke often show cognitive
impairment, as evident in standardized neuropsychological
tests or clinical observation. Cognitive neurorehabilitation
aims to remediate or compensate for decreased cognitive
abilities.17 It thus relies on the fundamental principle that
the brain has an inherent plasticity that enables it to recover
from damage that provoked cognitive impairment. Further-
more, it relies on the possibility that individuals have the
capacity to make behavioral adjustments that are necessary
due to changing circumstances. Finally, there is a growing
appreciation of the influence of contextual variables such
as personal, emotional, and social factors.
In our neurorehabilitation, we treat stroke patients with
impaired attention, memory, language, or executive func-
tions with different therapeutic approaches. A main focus is
on the therapy of spatial hemineglect, defined as the failure
to attend, explore, and act upon the contralesional side of
space. Spatial hemineglect usually occurs after damage to
the language-nondominant hemisphere and is therefore
Kamm et al. 3
Figure 2. Graphical presentation of functional improvement. Spider diagram of the total LIMOS which demonstrates mean admission
values (blue) versus discharge mean values (red) of each of the seven chapters (interpersonal interactions and relationships, mobility,
self-care, communication, learning and applying knowledge, general tasks and demands, and domestic life). These seven chapters cover
the 45 items of the total LIMOS. LIMOS: Lucerne International Classification of Functioning-based multidisciplinary observation scale.
Figure 3. LIMOS results at admission and discharge of the inpatient neurorehabilitation and neurorehabilitation day clinic. LIMOS:
Lucerne International Classification of Functioning-based multidisciplinary observation scale.
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typically found in patients who have suffered right-
hemispheric stroke. Traditionally, this disorder of spatial
attention is treated with visual exploration techniques,
requiring patients to more actively explore the neglected
hemispace. We have recently shown that additional non-
invasive brain stimulation can improve and accelerate
recovery from neglect and—associated with it—can further
improve general functional outcome (Figure 4).15
Multiple sclerosis
MS is a chronic inflammatory disease of the central ner-
vous system and the most common cause of non-traumatic
disability in young adults in western countries.18 Despite
increasing therapeutic options to ameliorate the disease
course, most patients suffer from persistent neurological
deficits over time.
Neurologic symptoms can be manifold and highly
variable among patients. Therefore, a patient-tailored mul-
timodal treatment is mandatory for the successful neuror-
ehabilitation.19 To do so, MS patients are treated in all
mentioned entities in the neurocenter, depending on the
deficits of patients and living conditions. To specifically
address the needs of patients in a standardized way, we
developed several additional treatment entities for MS
patients.
“MS-FIT” is a standardized comprehensive ambulatory
neurorehabilitation program that was developed to offer
standardized high frequency training in a hospital-based
ambulatory setting with the goal to improve disability and
consecutively ADL and quality of life (QoL) of patients.
Patients perform a circuit training consisting of six work-
stations (endurance, strength, flexibility, balance, dexter-
ity, and reaction) in groups of three to six patients, 2 h,
twice a week for 2 months, supervised by specialized
physical therapists. MS-FIT was performed within a clin-
ical study at the Cantonal Hospital Lucerne and Univer-
sity Hospital Bern (ClinicalTrials.gov Identifier:
NCT02440516). It was finalized in March 2019 and the
results will follow soon. It was feasible and highly
accepted by patients and will now be integrated outpatient
neurorehabilitation as treatment entity.
Cognitive MS training groups
Cognitive impairment is found in at least 40% of MS
patients, during all stages of the disease, and negatively
affects QoL as well as vocational capacity.20 Concerning
the rehabilitation of these deficits, a combination of resti-
tutive and compensatory approaches seems most effec-
tive.21 The former directly treats the impaired function
(e.g. processing speed and working memory), should be
deficit-specific, and can nowadays easily be performed
by the patients themselves, for example, on mobile com-
munication devices. On the other hand, learning compen-
satory strategies is usually taught by therapists. We
developed two such compensatory cognitive training pro-
tocols in 2017, each incorporated in an occupational group
therapy over nine sessions: (a) MS-MEMO is based on
well-established (e.g. Chiaravallotti et al.22) visual imagery
and storytelling techniques to increase verbal memory per-
formance in everyday situations (e.g. remembering names,
shopping items, or passwords) and (b) MS-PLAN adopts
goal management training strategies to improve planning
and problem-solving capabilities of patients.23
Home-based training programs specifically developed
for MS patient are offered as well, currently mostly within
studies. We recently showed that a standardized 4-week
home-based dexterity training program with traditional
training methods such as “turning metal discs,” “turning
nuts on bolts,” and “finger tapping” exercises significantly
improved manual dexterity and dexterity-related ADL in
MS patients with subjectively and objectively impaired
manual dexterity.24
Currently, we perform as similar study called “App-
Based Dexterity Training in Multiple Sclerosis” (Clinical-
Trials.gov Identifier: NCT03369470) that investigates if an
app-based dexterity training (“Finger Zirkus”; www.fin-
gers-in-motion.de) performed on a tablet computer is effec-
tive in improving manual dexterity in MS patients
(Figure 5).25
As further steps, we perform a feasibility study using a
device, which is able to combine gamification and virtual
reality (VR). This leap motion controller (LMC) is a low-
Figure 4. Continuous theta burst stimulation improves activities
of daily living in neglect patients. Significant improvement of ADL
in neglect patients after both 8 and 16 trains of cTBS versus sham,
as demonstrated by the LIMOS. Total values between admission
to and discharge from neurorehabilitation (*p < 0.05). ADL:
activities of daily living; LIMOS: Lucerne International Classifica-
tion of Functioning-based multidisciplinary observation scale;
cTBS: continuous theta burst stimulation.
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cost system with camera sensors that track and quantify
hand movements and gestures (Figure 5). The aim of the
study is to investigate whether VR LMC training, focused
on manual dexterity, is feasible in patients with MS.26 In
addition, preliminary data on the impact of the training
program on manual dexterity will be collected. If feasibly,
bigger controlled studies will be performed with regard to
the effectivity of such a training program in improving
manual dexterity in MS patients.
In our opinion, expanding ambulatory and home-based
therapies in MS is essential to address the needs of patients
because modern drug therapies increasingly prevent severe
disability minimizing the need of inpatient rehabilitation as
shown in our clinic with only 2% inpatient MS patients.
Parkinson’s disease
PD is a progressive neurodegenerative disorder that
predominately affects motor and nonmotor basal ganglia
circuitry.27 The degeneration of dopaminergic neurons in
the substantia nigra leads to the clinical manifestation of
the cardinal motor features of PD: bradykinesia, muscle
rigidity, tremor at rest, and impairment of postural
reflexes.27 While dopaminergic therapy improves some
symptoms of PD, other symptoms, such as impaired finger
dexterity and freezing of gait (FOG), may be less respon-
sive to pharmacological treatment. There is increasing
evidence that allied health care is associated with fewer
PD-related complications and may improve ADL.28,29 Our
neurocenter offers specific treatments, such as the Lee
Silverman voice treatment LOUD and BIG therapy, which
are specific high-intensity training protocols to improve
speech on the one hand (LOUD) and movement (BIG) on
the other hand.30,31 Furthermore, sensory cueing is applied
which has been shown to be effective to initiate, to main-
tain movements, or to overcome FOG.32 Additionally, we
offer group therapy to improve psychological well-being
and consequently QoL. Finally, an important clinical and
research focus is impaired manual dexterity in PD. We
developed a home-based dexterity training called HOME-
DEXT (similar to the program previously published by
Kamm et al. 2014 for MS), which proved to be effective
in ameliorating manual dexterity in PD.14 Future research
projects will combine repetitive transcranial magnetic sti-
mulation (rTMS) with VR LMC video game-based dexter-
ity training, for example, within a randomized-controlled
trial supported by the Jacques and Gloria Gossweiler Foun-
dation. By combining rTMS with VR LMC, we expect to
achieve longer lasting effects on dexterous performance. In
a recently accepted pilot study, we were already able to
demonstrate feasibility and short-term effects on dexterity
using VR LMC in PD.26
Conclusion
Patient-tailored neurorehabilitation is essential in numer-
ous neurological diseases. This implies rehabilitative treat-
ment from disease onset as well as flexible multimodal
rehabilitation in chronic diseases. The neurocenter of the
Cantonal Hospital Lucerne therefore established an unin-
terrupted interdisciplinary treatment chain from the emer-
gency stage to the social and occupational reintegration.
Within this treatment chain, neurorehabilitation is offered
in different entities (neuropath, inpatient neurorehabilita-
tion, neurorehabilitation day clinic, outpatient neuroreh-
abilitation, and home-based training) to ensure an optimal
treatment adapted to the needs of patients.
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